{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T15:38:54Z","timestamp":1794411534759,"version":"4.9.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:00:00Z","timestamp":1453852800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"NCI Cancer Center Support Grant","award":["P30CA16672"],"award-info":[{"award-number":["P30CA16672"]}]},{"DOI":"10.13039\/100000869","name":"Susan G. Komen for the Cure","doi-asserted-by":"publisher","award":["BCTR0707808"],"award-info":[{"award-number":["BCTR0707808"]}],"id":[{"id":"10.13039\/100000869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000869","name":"Susan G. Komen for the Cure","doi-asserted-by":"publisher","award":["KG090422"],"award-info":[{"award-number":["KG090422"]}],"id":[{"id":"10.13039\/100000869","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["T32 CA 113275-5"],"award-info":[{"award-number":["T32 CA 113275-5"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["NCI P50 CA 94056"],"award-info":[{"award-number":["NCI P50 CA 94056"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000090","name":"Congressionally Directed Medical Research Programs","doi-asserted-by":"publisher","award":["W81XWH-11-1-0616"],"award-info":[{"award-number":["W81XWH-11-1-0616"]}],"id":[{"id":"10.13039\/100000090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004917","name":"Cancer Prevention and Research Institute of Texas","doi-asserted-by":"publisher","award":["RP150148"],"award-info":[{"award-number":["RP150148"]}],"id":[{"id":"10.13039\/100004917","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13058-016-0673-9","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T19:05:30Z","timestamp":1453835130000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer"],"prefix":"10.1186","volume":"18","author":[{"given":"Emily","family":"Powell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiansu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiang-Chun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirong","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria V.","family":"Echeverria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nipun","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith F.","family":"Decker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Schlosberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim-Anh","family":"Do","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Piwnica-Worms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Piwnica-Worms","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,1,27]]},"reference":[{"key":"673_CR1","doi-asserted-by":"publisher","first-page":"5649","DOI":"10.1158\/0008-5472.CAN-10-1040","volume":"70","author":"JE Talmadge","year":"2010","unstructured":"Talmadge JE, Fidler IJ. AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res. 2010;70:5649\u201369.","journal-title":"Cancer Res"},{"key":"673_CR2","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/ijc.27767","volume":"132","author":"A Dumay","year":"2013","unstructured":"Dumay A, Feugeas JP, Wittmer E, Lehmann-Che J, Bertheau P, Espie M, et al. Distinct tumor protein p53 mutants in breast cancer subgroups. Int J Cancer. 2013;132:1227\u201331.","journal-title":"Int J Cancer"},{"key":"673_CR3","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1158\/2159-8290.CD-13-0136","volume":"4","author":"E Powell","year":"2014","unstructured":"Powell E, Piwnica-Worms D, Piwnica-Worms H. Contribution of p53 to metastasis. Cancer Discov. 2014;4:405\u201314.","journal-title":"Cancer Discov"},{"key":"673_CR4","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1083\/jcb.201009059","volume":"192","author":"PA Muller","year":"2011","unstructured":"Muller PA, Vousden KH, Norman JC. p53 and its mutants in tumor cell migration and invasion. J Cell Biol. 2011;192:209\u201318.","journal-title":"J Cell Biol"},{"key":"673_CR5","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1126\/science.2144057","volume":"249","author":"SJ Baker","year":"1990","unstructured":"Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science. 1990;249:912\u20135.","journal-title":"Science"},{"key":"673_CR6","doi-asserted-by":"publisher","first-page":"7491","DOI":"10.1073\/pnas.89.16.7491","volume":"89","author":"SJ Kuerbitz","year":"1992","unstructured":"Kuerbitz SJ, Plunkett BS, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci U S A. 1992;89:7491\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"673_CR7","doi-asserted-by":"publisher","first-page":"4495","DOI":"10.1073\/pnas.89.10.4495","volume":"89","author":"P Shaw","year":"1992","unstructured":"Shaw P, Bovey R, Tardy S, Sahli R, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci U S A. 1992;89:4495\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"673_CR8","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.cell.2004.11.006","volume":"119","author":"GA Lang","year":"2004","unstructured":"Lang GA, Iwakuma T, Suh YA, Liu G, Rao VA, Parant JM, et al. Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome. Cell. 2004;119:861\u201372.","journal-title":"Cell"},{"key":"673_CR9","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cell.2004.11.004","volume":"119","author":"KP Olive","year":"2004","unstructured":"Olive KP, Tuveson DA, Ruhe ZC, Yin B, Willis NA, Bronson RT, et al. Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome. Cell. 2004;119:847\u201360.","journal-title":"Cell"},{"key":"673_CR10","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s000180050269","volume":"55","author":"LD Attardi","year":"1999","unstructured":"Attardi LD, Jacks T. The role of p53 in tumour suppression: lessons from mouse models. Cell Mol Life Sci. 1999;55:48\u201363.","journal-title":"Cell Mol Life Sci"},{"key":"673_CR11","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/nature10933","volume":"486","author":"SP Shah","year":"2012","unstructured":"Shah SP, Roth A, Goya R, Oloumi A, Ha G, Zhao Y, et al. The clonal and mutational evolution spectrum of primary triple-negative breast cancers. Nature. 2012;486:395\u20139.","journal-title":"Nature"},{"key":"673_CR12","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.1038\/nm.2454","volume":"17","author":"YS DeRose","year":"2011","unstructured":"DeRose YS, Wang G, Lin YC, Bernard PS, Buys SS, Ebbert MT, et al. Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes. Nat Med. 2011;17:1514\u201320.","journal-title":"Nat Med"},{"key":"673_CR13","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1158\/0008-5472.CAN-12-4081","volume":"73","author":"X Zhang","year":"2013","unstructured":"Zhang X, Claerhout S, Prat A, Dobrolecki LE, Petrovic I, Lai Q, et al. A renewable tissue resource of phenotypically stable, biologically and ethnically diverse, patient-derived human breast cancer xenograft models. Cancer Res. 2013;73:4885\u201397.","journal-title":"Cancer Res"},{"key":"673_CR14","doi-asserted-by":"publisher","first-page":"7406","DOI":"10.1158\/0008-5472.CAN-14-1188","volume":"74","author":"J Bockhorn","year":"2014","unstructured":"Bockhorn J, Prat A, Chang YF, Liu X, Huang S, Shang M, et al. Differentiation and loss of malignant character of spontaneous pulmonary metastases in patient-derived breast cancer models. Cancer Res. 2014;74:7406\u201317.","journal-title":"Cancer Res"},{"key":"673_CR15","doi-asserted-by":"publisher","first-page":"18115","DOI":"10.1073\/pnas.1006732107","volume":"107","author":"H Liu","year":"2010","unstructured":"Liu H, Patel MR, Prescher JA, Patsialou A, Qian D, Lin J, et al. Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proc Natl Acad Sci U S A. 2010;107:18115\u201320.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"673_CR16","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1172\/JCI58765","volume":"122","author":"CX Ma","year":"2012","unstructured":"Ma CX, Cai S, Li S, Ryan CE, Guo Z, Schaiff WT, et al. Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models. J Clin Invest. 2012;122:1541\u201352.","journal-title":"J Clin Invest"},{"key":"673_CR17","doi-asserted-by":"publisher","first-page":"4966","DOI":"10.1073\/pnas.0401064101","volume":"101","author":"C Kuperwasser","year":"2004","unstructured":"Kuperwasser C, Chavarria T, Wu M, Magrane G, Gray JW, Carey L, et al. Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A. 2004;101:4966\u201371.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"673_CR18","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/nmeth779","volume":"2","author":"S Gross","year":"2005","unstructured":"Gross S, Piwnica-Worms D. Real-time imaging of ligand-induced IKK activation in intact cells and in living mice. Nat Methods. 2005;2:607\u201314.","journal-title":"Nat Methods"},{"key":"673_CR19","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1104\/pp.95.2.498","volume":"95","author":"RB Jackson","year":"1991","unstructured":"Jackson RB, Woodrow IE, Mott KA. Nonsteady-state photosynthesis following an increase in photon flux density (PFD): effects of magnitude and duration of initial PFD. Plant Physiol. 1991;95:498\u2013503.","journal-title":"Plant Physiol"},{"key":"673_CR20","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1172\/JCI22320","volume":"115","author":"AJ Minn","year":"2005","unstructured":"Minn AJ, Kang Y, Serganova I, Gupta GP, Giri DD, Doubrovin M, et al. Distinct organ-specific metastatic potential of individual breast cancer cells and primary tumors. J Clin Invest. 2005;115:44\u201355.","journal-title":"J Clin Invest"},{"key":"673_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1038\/nature11453","volume":"490","author":"CGA Network","year":"2012","unstructured":"Network CGA. Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61\u201370.","journal-title":"Nature"},{"key":"673_CR22","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/S0140-6736(05)70933-8","volume":"365","author":"Y Wang","year":"2005","unstructured":"Wang Y, Klijn JG, Zhang Y, Sieuwerts AM, Look MP, Yang F, et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet. 2005;365:671\u20139.","journal-title":"Lancet"},{"key":"673_CR23","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1056\/NEJMoa021967","volume":"347","author":"MJ van de Vijver","year":"2002","unstructured":"van de Vijver MJ, He YD, van\u2019t Veer LJ, Dai H, Hart AA, Voskuil DW, et al. A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med. 2002;347:1999\u20132009.","journal-title":"N Engl J Med"},{"key":"673_CR24","doi-asserted-by":"publisher","first-page":"5635","DOI":"10.1158\/0008-5472.CAN-11-0489","volume":"71","author":"FM Buffa","year":"2011","unstructured":"Buffa FM, Camps C, Winchester L, Snell CE, Gee HE, Sheldon H, et al. microRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancer. Cancer Res. 2011;71:5635\u201345.","journal-title":"Cancer Res"},{"key":"673_CR25","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.celrep.2013.08.022","volume":"4","author":"S Li","year":"2013","unstructured":"Li S, Shen D, Shao J, Crowder R, Liu W, Prat A, et al. Endocrine-therapy-resistant ESR1 variants revealed by genomic characterization of breast-cancer-derived xenografts. Cell Rep. 2013;4:1116\u201330.","journal-title":"Cell Rep"},{"key":"673_CR26","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27:1160\u20137.","journal-title":"J Clin Oncol"},{"key":"673_CR27","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1101\/gad.1061803","volume":"17","author":"G Dontu","year":"2003","unstructured":"Dontu G, Abdallah WM, Foley JM, Jackson KW, Clarke MF, Kawamura MJ, et al. In vitro propagation and transcriptional profiling of human mammary stem\/progenitor cells. Genes Dev. 2003;17:1253\u201370.","journal-title":"Genes Dev"},{"key":"673_CR28","doi-asserted-by":"publisher","first-page":"3983","DOI":"10.1073\/pnas.0530291100","volume":"100","author":"M Al-Hajj","year":"2003","unstructured":"Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100:3983\u20138.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"673_CR29","doi-asserted-by":"publisher","first-page":"a003228","DOI":"10.1101\/cshperspect.a003228","volume":"3","author":"P Schedin","year":"2011","unstructured":"Schedin P, Keely PJ. Mammary gland ECM remodeling, stiffness, and mechanosignaling in normal development and tumor progression. Cold Spring Harb Perspect Biol. 2011;3:a003228.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"673_CR30","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.semcancer.2010.05.002","volume":"20","author":"D Bourboulia","year":"2010","unstructured":"Bourboulia D, Stetler-Stevenson WG. Matrix metalloproteinases (MMPs) and tissue inhibitors of metalloproteinases (TIMPs): Positive and negative regulators in tumor cell adhesion. Semin Cancer Biol. 2010;20:161\u20138.","journal-title":"Semin Cancer Biol"},{"key":"673_CR31","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/gcc.2870140113","volume":"14","author":"AL Borresen","year":"1995","unstructured":"Borresen AL, Andersen TI, Eyfjord JE, Cornelis RS, Thorlacius S, Borg A, et al. TP53 mutations and breast cancer prognosis: particularly poor survival rates for cases with mutations in the zinc-binding domains. Genes Chromosomes Cancer. 1995;14:71\u20135.","journal-title":"Genes Chromosomes Cancer"},{"key":"673_CR32","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1038\/nm1095-1029","volume":"1","author":"J Bergh","year":"1995","unstructured":"Bergh J, Norberg T, Sjogren S, Lindgren A, Holmberg L. Complete sequencing of the p53 gene provides prognostic information in breast cancer patients, particularly in relation to adjuvant systemic therapy and radiotherapy. Nat Med. 1995;1:1029\u201334.","journal-title":"Nat Med"},{"key":"673_CR33","doi-asserted-by":"publisher","first-page":"1968","DOI":"10.1038\/sj.bjc.6690628","volume":"80","author":"PD Pharoah","year":"1999","unstructured":"Pharoah PD, Day NE, Caldas C. Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis. Br J Cancer. 1999;80:1968\u201373.","journal-title":"Br J Cancer"},{"key":"673_CR34","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1186\/1471-2407-6-276","volume":"6","author":"MA Troester","year":"2006","unstructured":"Troester MA, Herschkowitz JI, Oh DS, He X, Hoadley KA, Barbier CS, et al. Gene expression patterns associated with p53 status in breast cancer. BMC Cancer. 2006;6:276.","journal-title":"BMC Cancer"},{"key":"673_CR35","doi-asserted-by":"publisher","first-page":"13550","DOI":"10.1073\/pnas.0506230102","volume":"102","author":"LD Miller","year":"2005","unstructured":"Miller LD, Smeds J, George J, Vega VB, Vergara L, Ploner A, et al. An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival. Proc Natl Acad Sci U S A. 2005;102:13550\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"673_CR36","doi-asserted-by":"publisher","first-page":"10869","DOI":"10.1073\/pnas.191367098","volume":"98","author":"T Sorlie","year":"2001","unstructured":"Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869\u201374.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"673_CR37","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/bcr1675","volume":"9","author":"A Langerod","year":"2007","unstructured":"Langerod A, Zhao H, Borgan O, Nesland JM, Bukholm IR, Ikdahl T, et al. TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer. Breast Cancer Res. 2007;9:R30.","journal-title":"Breast Cancer Res"},{"key":"673_CR38","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1101\/gad.1372606","volume":"20","author":"AD Boiko","year":"2006","unstructured":"Boiko AD, Porteous S, Razorenova OV, Krivokrysenko VI, Williams BR, Gudkov AV. A systematic search for downstream mediators of tumor suppressor function of p53 reveals a major role of BTG2 in suppression of Ras-induced transformation. Genes Dev. 2006;20:236\u201352.","journal-title":"Genes Dev"},{"key":"673_CR39","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S0014-5793(01)02436-X","volume":"497","author":"S Matsuda","year":"2001","unstructured":"Matsuda S, Rouault J, Magaud J, Berthet C. In search of a function for the TIS21\/PC3\/BTG1\/TOB family. FEBS Lett. 2001;497:67\u201372.","journal-title":"FEBS Lett"},{"key":"673_CR40","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/ng1296-482","volume":"14","author":"JP Rouault","year":"1996","unstructured":"Rouault JP, Falette N, Guehenneux F, Guillot C, Rimokh R, Wang Q, et al. Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet. 1996;14:482\u20136.","journal-title":"Nat Genet"},{"key":"673_CR41","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/j.cell.2014.07.013","volume":"158","author":"N Aceto","year":"2014","unstructured":"Aceto N, Bardia A, Miyamoto DT, Donaldson MC, Wittner BS, Spencer JA, et al. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell. 2014;158:1110\u201322.","journal-title":"Cell"},{"key":"673_CR42","doi-asserted-by":"publisher","first-page":"3084","DOI":"10.1038\/onc.2011.24","volume":"30","author":"F Takahashi","year":"2011","unstructured":"Takahashi F, Chiba N, Tajima K, Hayashida T, Shimada T, Takahashi M, et al. Breast tumor progression induced by loss of BTG2 expression is inhibited by targeted therapy with the ErbB\/HER inhibitor lapatinib. Oncogene. 2011;30:3084\u201395.","journal-title":"Oncogene"},{"key":"673_CR43","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/(SICI)1098-2744(200002)27:2<57::AID-MC1>3.0.CO;2-I","volume":"27","author":"U Cortes","year":"2000","unstructured":"Cortes U, Moyret-Lalle C, Falette N, Duriez C, Ghissassi FE, Barnas C, et al. BTG gene expression in the p53-dependent and -independent cellular response to DNA damage. Mol Carcinog. 2000;27:57\u201364.","journal-title":"Mol Carcinog"},{"key":"673_CR44","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/1471-2407-10-296","volume":"10","author":"E Mollerstrom","year":"2010","unstructured":"Mollerstrom E, Kovacs A, Lovgren K, Nemes S, Delle U, Danielsson A, et al. Up-regulation of cell cycle arrest protein BTG2 correlates with increased overall survival in breast cancer, as detected by immunohistochemistry using tissue microarray. BMC Cancer. 2010;10:296.","journal-title":"BMC Cancer"},{"key":"673_CR45","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3892\/ijo.2014.2765","volume":"46","author":"B Mao","year":"2015","unstructured":"Mao B, Zhang Z, Wang G. BTG2: A rising star of tumor suppressors (review). Int J Oncol. 2015;46:459\u201364.","journal-title":"Int J Oncol"},{"key":"673_CR46","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1002\/jcp.1062","volume":"187","author":"F Tirone","year":"2001","unstructured":"Tirone F. The gene PC3(TIS21\/BTG2), prototype member of the PC3\/BTG\/TOB family: regulator in control of cell growth, differentiation, and DNA repair? J Cell Physiol. 2001;187:155\u201365.","journal-title":"J Cell Physiol"},{"key":"673_CR47","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1038\/nature13952","volume":"518","author":"P Eirew","year":"2015","unstructured":"Eirew P, Steif A, Khattra J, Ha G, Yap D, Farahani H, et al. Dynamics of genomic clones in breast cancer patient xenografts at single-cell resolution. Nature. 2015;518:422\u20136.","journal-title":"Nature"},{"key":"673_CR48","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1038\/nature08989","volume":"464","author":"L Ding","year":"2010","unstructured":"Ding L, Ellis MJ, Li S, Larson DE, Chen K, Wallis JW, et al. Genome remodelling in a basal-like breast cancer metastasis and xenograft. Nature. 2010;464:999\u20131005.","journal-title":"Nature"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-016-0673-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-016-0673-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-016-0673-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-016-0673-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T09:02:56Z","timestamp":1589533376000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-016-0673-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["673"],"URL":"https:\/\/doi.org\/10.1186\/s13058-016-0673-9","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,1,27]]},"assertion":[{"value":"13 November 2015","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"13"}}